Abstract
5-HT has been implicated in the mechanisms of anxiety since the seminal studies of Graeff and Schoenfeld (1970) and Geller and Blum (1970). They showed that 5-HT receptor antagonists and inhibition of 5-HT synthesis prevented the ability of foot shock to suppress operant behaviour. The subsequent observation that the anxiolytic benzodiazepine oxazepam decreased 5-HT turnover lead to the suggestion that anxiolytic drugs work by inhibition of 5-HT function (Wise et al., 1972).
Preview
Unable to display preview. Download preview PDF.
References
Bolles, R. C. and Fanselow, M. S. (1980). A perceptual—defensive—recuperative model of fear and pain. Behav. Brain Sci., 3, 291–323.
Campbell, D., Sanderson, R. E. and Laverty, S. G. (1964). Characteristics of a conditioned response in human subjects during extinction trials following a single traumatic conditioning trial. J. Abn. Soc. Psychol., 6, 627–39.
Chapman, W. P., Shroeder, H. R., Geyer, G., Brazier, M. A. B., Fanger, C., Poppen, J. S., Solomon, H. C. and Iakolev, P. I. (1954). Physiological evidence concerning importance of the amygdaloid nuclear regions in the circulatory function and emotion in man. Science, 120, 949–50.
Crow, T. J. (1973). Catecholamine-neurones and self-stimulation. II: A theoretical interpretation and some psychiatry implications. Psychol. Med., 3, 66–73.
Crow, T. J. and Deakin, J. F. W. (1978). Brain reinforcement centres and psychoactive drugs. In Israel, Y., Glaser, F. B., Kalant, H., Popham, R. E., Schmidt, W. and Smart, R. G. (eds.), Recent Advances in Alcohol and Drug Problems, Plenum, New York, 25–76.
Davies, M. (1989). The role of the amygdaloid and its efferent projections in fear and anxiety. In Tryer, P. (ed.), Psychopharmacology of Anxiety, Oxford University Press, Oxford, 52–79.
Deakin, J. F. W. (1983). Roles of serotonergic systems in escape, avoidance and other behaviours. In Cooper, S. J. (ed.), Theory in Psychopharmacology, vol. 2, Academic Press, New York, 149–93.
Deakin, J. F. W. (1988). 5-HT2 receptors, depression and anxiety. Pharmacol. Biochem. Behav., 29, 819–20.
Deakin, J. F. W. (1990). Serotonin subtypes and affective disorder. In Idzikowski, C. and Cowen, P. (eds.), Serotonin, Sleep and Mental Disorder, Blackwell Scientific Publications (in press).
Deakin, J. F. W., Pennell, I., Upadhyaya, A. J. and Lofthouse, R. (1990). A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology, 101, 85–92.
Den Boer, J. A. (1988). Serotonergic Mechanisms in Anxiety Disorders. An Inquiry into Serotonin Function in Panic Disorder. Rijksuniversieteit te Utrecht, Utrecht.
Den Boer, J. A. and Westenberg, H. G. M. (1988). Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline. Int. Clin. Psychopharmacol., 3, 59–74.
Geller, I. and Blum, K. (1970). The effects of 5-HTP on parachlorophenylalanine (P-CPA) attenuation of conflict behavior. Europ. J. Pharmacol., 9, 319–24.
Goa, K. L. and Ward, A. (1986). Buspirone, a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs, 32, 114–29.
Goldberg, H. L. and Finnerty, R. J. (1979). The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am. J. Psychiatry, 136, 1184–7.
Graeff, F. G. (1989). Serotonin and aversion. In Bevan, P., Cools, A. R. and Archer, T. (eds.), Behavioural Pharmacology of 5HT, Lawrence Erlbaum, London, 425–43.
Graeff, F. G. and Schoenfeld, R. I. (1970). Tryptaminergic mechanisms in punished and nonpunished behaviour. J. Pharmacol. Exp. Ther., 173, 277–83.
Gray, J. A. (1982). The Neuropsychology of Anxiety, Oxford University Press, Oxford.
Gray, J. A. (1987). The Psychology of Fear and Stress, 2nd edn, Cambridge University Press, Cambridge.
Guimaraes, F. S., Hellewell, J., Wang, M. and Deakin, J. F. W. (1990). Sex difference in aversive classical conditioning and responsiveness to anxiolytic drugs in humans. Br. J. Clin. Pharmacol., 29, 141P–142P.
Guimaraes, F. S., Zuardi, A. W. and Graeff, F. G. (1987). Effect of chlorimipramine and maprotiline on experimental anxiety in humans. J. Psychopharmacol., 1, 184–92.
Hellewell, J., Hensman, R., Guimaraes, F. and Deakin, J. F. W. (1989). Effect of 5HT-active drugs on aversive conditioning in healthy volunteers. J. Psychopharmacol., 3, 111P.
Hodges, H., Green, S. and Glenn, B. (1987). Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology, 92, 491–504.
Johnston, D. G., Troyer, I. E. and Whitsett, S. F. (1988). Clomipramine treatment of agoraphobic women. Arch. Gen. Psychiatry, 45, 453–9.
Johnstone, E. C., Owens, D. G. C., Frith, C. D., McPherson, K., Dowie, C., Riley, G. and Gold, A. (1980). Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychological Med., 10, 321–8.
Kahn, R. J., McNair, D. M., Lipman, R. S., Covi, L., Rickels, K., Downing, R., Fisher, S. and Frankenthaler, L. M. (1986). Imipramine and chlordiazepoxide in depressive and anxiety disorders. II: Efficacy in anxious outpatients. Arch. Gen. Psychiatry, 43, 79–85.
Kataoka, Y., Schibata, K., Tamashita, K. and Ueki, S. (1987). Differential mechanisms involved in the anticonflict action of benzodiazepines injected into the central amygdala and mammillary body. Brain Res., 416, 243–7.
Kiser, R. S., Brown, C. A., Sanghera, M. K. and German, D. C. (1980). Dorsal raphe stimulation reduces centrally elicited fear like behavior. Brain Res., 191, 265–72.
Lista, A., Blier, P. and De Montigny, C. (1989). In vivo presynaptic modulation of serotonergic neurotransmission in the rat hippocampus by diazepam. Europ. J. Pharmacol., 171, 229–31.
Maltzman, I., Gould, J., Barnett, O. J., Raskin, D. C. and Wolff, C. (1979). Habituation of the GSR and digital vasomotor components of the orienting reflex as a consequence of task instructions and sex differences. Physiol. Psychol., 7, 213–20.
McNair, D. M. and Kahn, R. J. (1981). Imipramine compared with a benzodiazepine for agoraphobia. In Klein, D. F. and Rabkin, J. (eds.), Anxiety: New Research and Changing Concepts, Raven, New York, 69–80.
Medical Research Council (1965). Clinical trial of the treatment of depressive illness. Br. Med. J., 2, 881–6.
Nashold, B. S., Jr, Wilson, W. P. and Slaughter, D. G. (1969). Sensations evoked by stimulation in the midbrain of man. J. Neurosurg., 30, 14–24.
Petersen, E. N. and Scheel-Krueger, J. (1984). Anticonflict effects of 5HT antagonists by intraamygdaloid injection. Collegium Internationale Neuro-Psychopharmacologicum, 14th CINP, congress book of abstracts, 654.
Pitman, R. K. and Orr, S. P. (1986). Test of the conditioned model of neurosis: differential aversive conditioning of angry and neutral facial expressions in anxiety disorders patients. J. Abn. Psychol., 95, 208–13.
Sakurai-Yamashita, Y., Kataoka, Y., Yamashita, K., Miyazaki, A., Ushio, M., Mine, K., Niwa, M. and Ueki, S. (1989). Conflict behavior and dynamics of monoamines of various brain nuclei in rats. Neuropharmacol., 28, 1067–73.
Sano, K., Sekino, H. and Mayanagi, Y. (1972). Results of stimulation and destruction of posterior hippocampus in cases with violent, aggressive and restless behaviors. In Hitchcoch, E., Laitinen, L. and Vaernet, K. (eds.), Psychosurgery, Thomas, Springfield, 57.
Schenberg, L. C. and Graeff, F. G. (1978). Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines. Pharmacol. Biochem. Behav., 9, 287–95.
Segal, M., Azmitia, E. C. and Whitaker-Azmitia, P. M. (1989). Physiological effects of selective 5HT1a and 5HT1b ligands in rat hippocampus: comparison to 5HT. Brain Res., 502, 67–74.
Shibata, K., Kataoka, Y., Yamashita, K. and Ueki, S. (1986). An important role of the central amygdaloid nucleus and mammilary body in the mediation of conflict behavior in rats. Brain Res., 372, 159–62.
Soubrie, P. (1986). Reconciling the role of central serotonin neurones in human and animal behaviour. Behav. Brain Sci., 9, 319–64.
Turner, B. H., Mislikin, M. and Knapp, M. (1980). Organization of the amygdalopetal projections from modality-specific cortical association areas in the monkey. J. Comp. Neurol., 191, 515–43.
Tye, N. C., Everitt, B. J. and Iversen, S. D. (1977). 5-hydroxytryptamine and punishment. Nature, 268, 741–3.
Wise, C. D., Berger, B. D. and Stein, L. (1972). Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the rat brain. Science, 17, 180–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1991 Macmillan Publishers Limited
About this chapter
Cite this chapter
Deakin, J.F.W., GuimarĂ£es, F.S., Wang, M., Hellewell, J., Hensman, R. (1991). 5-HT Receptor Mechanisms in Human Anxiety. In: Briley, M., File, S.E. (eds) New Concepts in Anxiety. Palgrave, London. https://doi.org/10.1007/978-1-349-11847-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-349-11847-2_6
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-11849-6
Online ISBN: 978-1-349-11847-2
eBook Packages: EngineeringEngineering (R0)